Molecular reorganization of endocannabinoid signalling in Alzheimers disease

ISSN： 1460-2156

Source： Brain, Vol.134, Iss.4, 2011-04, pp. : 1041-1060

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcium Signalling and Alzheimer’s Disease

By Berridge Michael

Neurochemical Research, Vol. 36, Iss. 7, 2011-07 ,pp. : 1149-1156

Springer Publishing Company

Access to resources Recommend Favorite

Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa Rosner Margit Freilinger Angelika Lubec Gert Hengstschläger Markus

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite

On the Molecular Basis Linking Nerve Growth Factor (NGF) to Alzheimer’s Disease

By Capsoni Simona Cattaneo Antonino

Cellular and Molecular Neurobiology, Vol. 26, Iss. 4-6, 2006-07 ,pp. : 617-631

Springer Publishing Company

Access to resources Recommend Favorite

ADAM10: potential ‘molecular scissors’ for the treatment of Alzheimer’s disease

By Lichtenthaler Stefan F

Future Neurology, Vol. 6, Iss. 1, 2011-01 ,pp. : 1-4

Future Medicine

Access to resources Recommend Favorite

Alzheimer’s disease and schizophrenia: evidence of a specific, shared molecular background

By Prestia Annapaola

Future Neurology, Vol. 6, Iss. 1, 2011-01 ,pp. : 17-21

Future Medicine

Access to resources Recommend Favorite